Gemcitabine / Docetaxel combination chemotherapy for non-small cell lung cancer patient of safety confirmation test research

Not Applicable

• Conditions: non-small cell lung cancer

• Registration Number: JPRN-C000000098
• Lead Sponsor: agano Prefecture lung cancer chemotherapy Study Group

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2010-12-01
• Study Start: 2010-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

1.It a large amount is pericardial fluid with the subjective symptom is does pleural effusion or is a patient who admits as for the peritoneal fluid. 2.Patient with bone metastasis and brain metastasis focus where vena cava superior syndrome and pain are strong to need radiotherapy in emergency 3.It is a patient from whom the having infectious disease is doubted as for the patient and generation of heat that has the infectious disease. 4.It is a patient who has as for the syndrome of complication. 5.Patient who has clear tip neurological symptom (However, the one that originates in an original disease is excluded). 6.Patient who has the past of clear medicine hypersensitivity to treatment 7.Case from whom interstitial pneumonia or fibroid lung clear because of simple X rays of chest is admitted 8.Patient who has pregnant woman or possibility of pregnancy Case who judged that physician in charge is improper to this treatment object

Study & Design

• Study Type: Interventional
• Study Design: Not specified